Global Peptide-based Cancer Therapeutics Market Size, Share, and COVID-19 Impact Analysis, By Class (Peptide Hormone Analogues, Peptide-Drug Conjugates, and Vaccines/Others), By Indication (Prostate & Breast, Neuroendocrine/GI, and Melanoma/Others), By Line of Therapy (2L/3L, 1L, and Adjuvant/Others), and By Region (North America, Europe, Asia-Pacific, Latin America, Middle East, and Africa), Analysis and Forecast 2025 - 2035

Industry: Healthcare
RELEASE DATE Oct 2025
REPORT ID SI16235
PAGES 275
REPORT FORMAT PathSoft
Request Free Sample
Description Table of Contents Scope of Report Methodology
  1. Introduction
    1. Objectives of the Study
    2. Market Definition
    3. Research Scope
  2. Research Methodology and Assumptions
  3. Executive Summary
  4. Premium Insights
    1. Porter’s Five Forces Analysis
    2. Value Chain Analysis
    3. Top Investment Pockets
      1. Market Attractiveness Analysis, By Class
      2. Market Attractiveness Analysis, By Indication
      3. Market Attractiveness Analysis, By Line of Therapy
      4. Market Attractiveness Analysis, By Region
    4. Industry Trends
  5. Market Dynamics
    1. Market Evaluation
    2. Drivers
      1. Growing burden of cancer, along with its increasing mortality rates
    3. Restraints
      1.  Increased development costs and regulatory challenges
    4. Opportunities
      1.  Increased investment in R&D activities by manufacturers
    5. Challenges
      1. Limited bioavailability
  6. Global Peptide-based Cancer Therapeutics Market Analysis and Projection, By Class
    1. Segment Overview
    2. Peptide Hormone Analogues
    3. Peptide-Drug Conjugates
    4. Vaccines/Others
  7. Global Peptide-based Cancer Therapeutics Market Analysis and Projection, By Indication
    1. Segment Overview
    2. Prostate & Breast
    3. Neuroendocrine/GI
    4. Melanoma/Others
  8. Global Peptide-based Cancer Therapeutics Market Analysis and Projection, By Line of Therapy
    1. Segment Overview
    2. 2L/3L
    3. 1L
    4. Adjuvant/Others
  9. Global Peptide-based Cancer Therapeutics Market Analysis and Projection, By Regional Analysis
    1. Segment Overview
    2. North America
      1. U.S.
      2. Canada
      3. Mexico
    3. Europe
      1. Germany
      2. France
      3. U.K.
      4. Italy
      5. Spain
    4. Asia-Pacific
      1. Japan
      2. China
      3. India
    5. South America
      1. Brazil
    6. Middle East and Africa
      1. UAE
      2. South Africa
  10. Global Peptide-based Cancer Therapeutics Market-Competitive Landscape
    1. Overview
    2. Market Share of Key Players in the Peptide-based Cancer Therapeutics Market
      1. Global Company Market Share
      2. North America Company Market Share
      3. Europe Company Market Share
      4. APAC Company Market Share
    3. Competitive Situations and Trends
      1. Coverage Launches and Developments
      2. Partnerships, Collaborations, and Agreements
      3. Mergers & Acquisitions
      4. Expansions
  11. Company Profiles
    1. Novartis AG
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    2.   Ipsen SA 
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    3.  AbbVie Inc. 
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    4.   Amgen Inc. 
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    5.   AstraZeneca PLC 
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    6.  Bristol Myers Squibb Company (BMS)
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    7.   Takeda Pharmaceutical Company Limited
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    8. Merck & Co. Inc.
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    9.  Roche Holding AG
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    10.  Eli Lilly and Company 
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    11.  Others
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis

 

List of Tables

  1. Global Peptide-based Cancer Therapeutics Market, By Class, 2024-2035(USD Billion)
  2. Global Peptide Hormone Analogues, Peptide-based Cancer Therapeutics Market, By Region, 2024-2035(USD Billion)
  3. Global Peptide-Drug Conjugates, Peptide-based Cancer Therapeutics Market, By Region, 2024-2035(USD Billion)
  4. Global Vaccines/Others, Peptide-based Cancer Therapeutics Market, By Region, 2024-2035(USD Billion)
  5. Global Peptide-based Cancer Therapeutics Market, By Indication, 2024-2035(USD Billion)
  6. Global Prostate & Breast, Peptide-based Cancer Therapeutics Market, By Region, 2024-2035(USD Billion)
  7. Global Neuroendocrine/GI, Peptide-based Cancer Therapeutics Market, By Region, 2024-2035(USD Billion)
  8. Global Melanoma/Others, Peptide-based Cancer Therapeutics Market, By Region, 2024-2035(USD Billion)
  9. Global Peptide-based Cancer Therapeutics Market, By Line of Therapy, 2024-2035(USD Billion)
  10. Global 2L/3L, Peptide-based Cancer Therapeutics Market, By Region, 2024-2035(USD Billion)
  11. Global 1L, Peptide-based Cancer Therapeutics Market, By Region, 2024-2035(USD Billion)
  12. Global Adjuvant/Others, Peptide-based Cancer Therapeutics Market, By Region, 2024-2035(USD Billion)
  13. North America Peptide-based Cancer Therapeutics Market, By Class, 2024-2035(USD Billion)
  14. North America Peptide-based Cancer Therapeutics Market, By Indication, 2024-2035(USD Billion)
  15. North America Peptide-based Cancer Therapeutics Market, By Line of Therapy, 2024-2035(USD Billion)
  16. U.S.  Peptide-based Cancer Therapeutics Market, By Class, 2024-2035(USD Billion)
  17. U.S.  Peptide-based Cancer Therapeutics Market, By Indication, 2024-2035(USD Billion)
  18. U.S.  Peptide-based Cancer Therapeutics Market, By Line of Therapy, 2024-2035(USD Billion)
  19. Canada Peptide-based Cancer Therapeutics Market, By Class, 2024-2035(USD Billion)
  20. Canada Peptide-based Cancer Therapeutics Market, By Indication, 2024-2035(USD Billion)
  21. Canada Peptide-based Cancer Therapeutics Market, By Line of Therapy, 2024-2035(USD Billion)
  22. Mexico Peptide-based Cancer Therapeutics Market, By Class, 2024-2035(USD Billion)
  23. Mexico Peptide-based Cancer Therapeutics Market, By Indication, 2024-2035(USD Billion)
  24. Mexico Peptide-based Cancer Therapeutics Market, By Line of Therapy, 2024-2035(USD Billion)
  25. Europe Peptide-based Cancer Therapeutics Market, By Class, 2024-2035(USD Billion)
  26. Europe Peptide-based Cancer Therapeutics Market, By Indication, 2024-2035(USD Billion)
  27. Europe Peptide-based Cancer Therapeutics Market, By Line of Therapy, 2024-2035(USD Billion)
  28. Germany Peptide-based Cancer Therapeutics Market, By Class, 2024-2035(USD Billion)
  29. Germany Peptide-based Cancer Therapeutics Market, By Indication, 2024-2035(USD Billion)
  30. Germany Peptide-based Cancer Therapeutics Market, By Line of Therapy, 2024-2035(USD Billion)
  31. France Peptide-based Cancer Therapeutics Market, By Class, 2024-2035(USD Billion)
  32. France Peptide-based Cancer Therapeutics Market, By Indication, 2024-2035(USD Billion)
  33. France Peptide-based Cancer Therapeutics Market, By Line of Therapy, 2024-2035(USD Billion)
  34. U.K.  Peptide-based Cancer Therapeutics Market, By Class, 2024-2035(USD Billion)
  35. U.K.  Peptide-based Cancer Therapeutics Market, By Indication, 2024-2035(USD Billion)
  36. U.K.  Peptide-based Cancer Therapeutics Market, By Line of Therapy, 2024-2035(USD Billion)
  37. Italy Peptide-based Cancer Therapeutics Market, By Class, 2024-2035(USD Billion)
  38. Italy Peptide-based Cancer Therapeutics Market, By Indication, 2024-2035(USD Billion)
  39. Italy Peptide-based Cancer Therapeutics Market, By Line of Therapy, 2024-2035(USD Billion)
  40. Spain Peptide-based Cancer Therapeutics Market, By Class, 2024-2035(USD Billion)
  41. Spain Peptide-based Cancer Therapeutics Market, By Indication, 2024-2035(USD Billion)
  42. Spain Peptide-based Cancer Therapeutics Market, By Line of Therapy, 2024-2035(USD Billion)
  43. Asia Pacific Peptide-based Cancer Therapeutics Market, By Class, 2024-2035(USD Billion)
  44. Asia Pacific Peptide-based Cancer Therapeutics Market, By Indication, 2024-2035(USD Billion)
  45. Asia Pacific Peptide-based Cancer Therapeutics Market, By Line of Therapy, 2024-2035(USD Billion)
  46. Japan Peptide-based Cancer Therapeutics Market, By Class, 2024-2035(USD Billion)
  47. Japan Peptide-based Cancer Therapeutics Market, By Indication, 2024-2035(USD Billion)
  48. Japan Peptide-based Cancer Therapeutics Market, By Line of Therapy, 2024-2035(USD Billion)
  49. China Peptide-based Cancer Therapeutics Market, By Class, 2024-2035(USD Billion)
  50. China Peptide-based Cancer Therapeutics Market, By Indication, 2024-2035(USD Billion)
  51. China Peptide-based Cancer Therapeutics Market, By Line of Therapy, 2024-2035(USD Billion)
  52. India Peptide-based Cancer Therapeutics Market, By Class, 2024-2035(USD Billion)
  53. India Peptide-based Cancer Therapeutics Market, By Indication, 2024-2035(USD Billion)
  54. India Peptide-based Cancer Therapeutics Market, By Line of Therapy, 2024-2035(USD Billion)
  55. South America Peptide-based Cancer Therapeutics Market, By Class, 2024-2035(USD Billion)
  56. South America Peptide-based Cancer Therapeutics Market, By Indication, 2024-2035(USD Billion)
  57. South America Peptide-based Cancer Therapeutics Market, By Line of Therapy, 2024-2035(USD Billion)
  58. Brazil Peptide-based Cancer Therapeutics Market, By Class, 2024-2035(USD Billion)
  59. Brazil Peptide-based Cancer Therapeutics Market, By Indication, 2024-2035(USD Billion)
  60. Brazil Peptide-based Cancer Therapeutics Market, By Line of Therapy, 2024-2035(USD Billion)
  61. The Middle East and Africa Peptide-based Cancer Therapeutics Market, By Class, 2024-2035(USD   Billion)
  62. The Middle East and Africa Peptide-based Cancer Therapeutics Market, By Indication, 2024-2035(USD   Billion)
  63. The Middle East and Africa Peptide-based Cancer Therapeutics Market, By Line of Therapy, 2024-2035(USD Billion)
  64. UAE Peptide-based Cancer Therapeutics Market, By Class, 2024-2035(USD Billion)
  65. UAE Peptide-based Cancer Therapeutics Market, By Indication, 2024-2035(USD Billion)
  66. UAE Peptide-based Cancer Therapeutics Market, By Line of Therapy, 2024-2035(USD Billion)
  67. South Africa Peptide-based Cancer Therapeutics Market, By Class, 2024-2035(USD Billion)
  68. South Africa Peptide-based Cancer Therapeutics Market, By Indication, 2024-2035(USD Billion)
  69. South Africa Peptide-based Cancer Therapeutics Market, By Line of Therapy, 2024-2035(USD Billion)

 

List of Figures 

  1. Global Peptide-based Cancer Therapeutics Market Segmentation
  2. Peptide-based Cancer Therapeutics Market: Research Methodology
  3. Market Size Estimation Methodology: Bottom-Up Approach
  4. Market Size Estimation Methodology: Top-down Approach
  5. Data Triangulation
  6. Porter’s Five Forces Analysis
  7. Value Chain Analysis
  8. Top investment pocket in the Peptide-based Cancer Therapeutics Market
  9. Top Winning Strategies, 2024-2035
  10. Top Winning Strategies, By Development, 2024-2035(%)
  11. Top Winning Strategies, By Company, 2024-2035
  12. Moderate Bargaining Power of Buyers
  13. Moderate Bargaining Power of Suppliers
  14. Moderate Bargaining Power of New Entrants
  15. Low threat of Substitution
  16. High Competitive Rivalry
  17. Top Player Positioning, 2024
  18. Market Share Analysis, 2024
  19. Restraint and Drivers:  Peptide-based Cancer Therapeutics Market
  20. Peptide-based Cancer Therapeutics Market Segmentation, By Class
  21. Peptide-based Cancer Therapeutics Market For Peptide Hormone Analogues, By Region, 2024-2035 ($ Billion)
  22.  Peptide-based Cancer Therapeutics Market For Peptide-Drug Conjugates, By Region, 2024-2035 ($ Billion)
  23. Peptide-based Cancer Therapeutics Market For Vaccines/Others, By Region, 2024-2035 ($ Billion)
  24.  Peptide-based Cancer Therapeutics Market Segmentation, By Indication
  25.  Peptide-based Cancer Therapeutics Market For Prostate & Breast, By Region, 2024-2035 ($ Billion)
  26.  Peptide-based Cancer Therapeutics Market For Neuroendocrine/GI, By Region, 2024-2035 ($ Billion)
  27. Peptide-based Cancer Therapeutics Market For Melanoma/Others, By Region, 2024-2035 ($ Billion)
  28. Peptide-based Cancer Therapeutics Market Segmentation, By Line of Therapy
  29. Peptide-based Cancer Therapeutics Market For 2L/3L, By Region, 2024-2035 ($ Billion)
  30. Peptide-based Cancer Therapeutics Market For 1L, By Region, 2024-2035 ($ Billion)
  31. Peptide-based Cancer Therapeutics Market For Adjuvant/Others, By Region, 2024-2035 ($ Billion)
  32. Novartis AG: Net Sales, 2024-2035 ($ Billion)
  33. Novartis AG: Revenue Share, By Segment, 2024 (%)
  34. Novartis AG: Revenue Share, By Region, 2024 (%)
  35. Ipsen SA: Net Sales, 2024-2035 ($ Billion)
  36. Ipsen SA: Revenue Share, By Segment, 2024 (%)
  37. Ipsen SA: Revenue Share, By Region, 2024 (%)
  38. AbbVie Inc.: Net Sales, 2024-2035 ($ Billion)
  39. AbbVie Inc.: Revenue Share, By Segment, 2024 (%)
  40. AbbVie Inc.: Revenue Share, By Region, 2024 (%)
  41. Amgen Inc.: Net Sales, 2024-2035 ($ Billion)
  42. Amgen Inc.: Revenue Share, By Segment, 2024 (%)
  43. Amgen Inc.: Revenue Share, By Region, 2024 (%)
  44. AstraZeneca PLC: Net Sales, 2024-2035 ($ Billion)
  45. AstraZeneca PLC: Revenue Share, By Segment, 2024 (%)
  46. AstraZeneca PLC: Revenue Share, By Region, 2024 (%)
  47. Bristol Myers Squibb Company (BMS): Net Sales, 2024-2035 ($ Billion)
  48. Bristol Myers Squibb Company (BMS): Revenue Share, By Segment, 2024 (%)
  49. Bristol Myers Squibb Company (BMS): Revenue Share, By Region, 2024 (%)
  50. Takeda Pharmaceutical Company Limited: Net Sales, 2024-2035 ($ Billion)
  51. Takeda Pharmaceutical Company Limited: Revenue Share, By Segment, 2024 (%)
  52. Takeda Pharmaceutical Company Limited: Revenue Share, By Region, 2024 (%)
  53. Merck & Co. Inc.: Net Sales, 2024-2035 ($ Billion)
  54. Merck & Co. Inc.: Revenue Share, By Segment, 2024 (%)
  55. Merck & Co. Inc.: Revenue Share, By Region, 2024 (%)
  56. Roche Holding AG.: Net Sales, 2024-2035 ($ Billion)
  57. Roche Holding AG.: Revenue Share, By Segment, 2024 (%)
  58. Roche Holding AG.: Revenue Share, By Region, 2024 (%)
  59. Eli Lilly and Company: Net Sales, 2024-2035 ($ Billion)
  60. Eli Lilly and Company: Revenue Share, By Segment, 2024 (%)
  61. Eli Lilly and Company: Revenue Share, By Region, 2024 (%)
  62. Others: Net Sales, 2024-2035 ($ Billion)
  63. Others: Revenue Share, By Segment, 2024 (%)
  64. Others: Revenue Share, By Region, 2024 (%)

Buy Now

  • Access to only 1 person; cannot be shared; cannot be printed
  • Access for 2 to 5 users only within same department of one company
  • Access to a company wide audience; includes subsidiary companies or other companies within a group of companies

Premium Report Details

Base Year:2024
Tables & Figures:110
Pages:275
Countries covered:14
Companies covered::14
Forecast CAGR:9.44%
Request Discount

15% Free Customization

Share your Requirements

Request Customization

We Covered in Market

  • 24/7 Analyst Support
  • Worldwide Clients
  • Tailored Insights
  • Technology Evolution
  • Competitive Intelligence
  • Custom Research
  • Syndicated Market Research
  • Market Snapshot
  • Market Segmentation
  • Growth Dynamics
  • Market Opportunities
  • Regulatory Overview
  • Innovation & Sustainability

Connect with us

Need help to buy this report?

Inquiry Before Buy
We'll use cookies to improve and customize your experience if you continue to browse. Is it OK if we also use cookies to show you personalized ads?
Learn more and manage your cookies
Yes, Accept Cookies